Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF(©)) and determination of a threshold score for moderate symptoms

por Shields, Alan L., Taylor, Fiona, Lamoureux, Roger E., Padilla, Brad, Severson, Kas, Green, Tanya, Boral, Anthony L., Akin, Cem, Siebenhaar, Frank, Mar, Brenton
Publicado 2023

Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF(©)

por Taylor, Fiona, Akin, Cem, Lamoureux, Roger E., Padilla, Brad, Green, Tanya, Boral, Anthony L., Mazar, Iyar, Mar, Brenton, Shields, Alan L., Siebenhaar, Frank
Publicado 2021

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors

por Nishio, Makoto, Murakami, Haruyasu, Horiike, Atsushi, Takahashi, Toshiaki, Hirai, Fumihiko, Suenaga, Naoko, Tajima, Takeshi, Tokushige, Kota, Ishii, Masami, Boral, Anthony, Robson, Matthew, Seto, Takashi
Publicado 2015

Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study

por Padilla, Brad, Shields, Alan L., Taylor, Fiona, Li, Xiaoran, Mcdonald, Jeffrey, Green, Tanya, Boral, Anthony L., Lin, Hui-Min, Akin, Cem, Siebenhaar, Frank, Mar, Brenton
Publicado 2021